Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2022 Filed Jan 31, 2022 16:24 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 1,801,801 | $1.11 | $1,999,999.11 |
DisclosureSEC source: 0001062993-22-001867 · form4.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 11,580,436 F3 · shares: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F3 · balance_after: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F4 · balance_after: Includes 967,983 shares previously reported as being held indirectly through FCMI Financial Corporation. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 16:24 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 1,801,801 | $1.11 | $1,999,999.11 |
DisclosureSEC source: 0001062993-22-001867 · form4.xml · nonDerivative · entry 3 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Friedberg Global-Macro Hedge Fund Ltd. Disclosed balance after: 3,511,894 F2 · shares: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F2 · balance_after: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F2 · ownership.nature: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 16:23 UTC |
Zauderer MauriceDirector · President and CEO
|
PurchaseCommon Stock | 1,801,801 | $1.11 | $1,999,999.11 |
DisclosureSEC source: 0001062993-22-001866 · form4.xml · nonDerivative · entry 4 Zauderer Maurice · CIK 0001747753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Vaccinex (Rochester), L.L.C. Disclosed balance after: 2,899,554 F2 · shares: Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F2 · balance_after: Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. F2 · ownership.nature: Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 16:17 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 12,856 | $0.68 Strike: $1.04 | $8,742.08 |
DisclosureSEC source: 0001062993-22-000063 · form4.xml · derivative · entry 19 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,856 Underlying: Common Stock · 12,856 shares Expires 2031-12-29 F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2021. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 16:22 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 6,233 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0000891839-21-000316 · edgar.xml · derivative · entry 18 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,233 Underlying: Common Stock · 6,233 shares Expires not disclosed F8 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, expires on September 28, 2031. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 16:07 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 4,804 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0000891839-21-000247 · edgar.xml · derivative · entry 17 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,804 Underlying: Common Stock · 4,804 shares Expires not disclosed F7 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, expires on June 28, 2031. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 16:31 UTC |
Frieberg Jacob B.Director
|
ConversionOption (Right to Acquire) · Derivative | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000234 · edgar.xml · derivative · entry 6 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gee Eff Services Limited Disclosed balance after: 0 Underlying: Common Stock · 4,121 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F2 · derivative.exercise_price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F2 · price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F2 · derivative.exercise_date: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F2 · derivative.expiration_date: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F4 · ownership.nature: Mr. Frieberg is the sole owner and President of Gee Eff Services Limited. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 16:31 UTC |
Frieberg Jacob B.Director
|
ConversionOption (Right to Acquire) · Derivative | 44,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000234 · edgar.xml · derivative · entry 5 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Benbow Estates, Ltd. Disclosed balance after: 0 Underlying: Common Stock · 4,420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F1 · derivative.exercise_price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F1 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F1 · derivative.exercise_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F1 · derivative.expiration_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F3 · ownership.nature: Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 16:31 UTC |
Frieberg Jacob B.Director
|
ConversionOption (Right to Acquire) · Derivative | 44,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000234 · edgar.xml · derivative · entry 4 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F1 · derivative.exercise_price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F1 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F1 · derivative.exercise_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F1 · derivative.expiration_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 16:31 UTC |
Frieberg Jacob B.Director
|
ConversionCommon Stock | 4,121 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000234 · edgar.xml · nonDerivative · entry 3 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Gee Eff Services Limited Disclosed balance after: 4,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F4 · ownership.nature: Mr. Frieberg is the sole owner and President of Gee Eff Services Limited. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 16:31 UTC |
Frieberg Jacob B.Director
|
ConversionCommon Stock | 4,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000234 · edgar.xml · nonDerivative · entry 2 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Benbow Estates, Ltd. Disclosed balance after: 4,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F3 · ownership.nature: Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 16:31 UTC |
Frieberg Jacob B.Director
|
ConversionCommon Stock | 4,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000234 · edgar.xml · nonDerivative · entry 1 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. Read SEC document |
| May 24, 2021 Filed Jun 24, 2021 16:41 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
ConversionOption (Right to Acquire) · Derivative | 9,679,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000232 · edgar.xml · derivative · entry 7 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Financial Corporation Disclosed balance after: 0 Underlying: Common Stock · 967,983 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F6 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F6 · derivative.exercise_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F6 · derivative.expiration_date: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F4 · ownership.nature: FCMI Financial Corp. is a wholly-owned subsidiary of FCMI Parent Co. Mr. Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein. Read SEC document |
| May 24, 2021 Filed Jun 24, 2021 16:41 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
ConversionOption (Right to Acquire) · Derivative | 21,475,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000232 · edgar.xml · derivative · entry 6 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 0 Underlying: Common Stock · 1,180,051 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F5 · price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F5 · derivative.exercise_date: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F5 · derivative.expiration_date: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 24, 2021 Filed Jun 24, 2021 16:41 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
ConversionCommon Stock | 967,983 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000232 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Financial Corporation Disclosed balance after: 967,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis. F4 · ownership.nature: FCMI Financial Corp. is a wholly-owned subsidiary of FCMI Parent Co. Mr. Friedberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein. Read SEC document |
| May 24, 2021 Filed Jun 24, 2021 16:41 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
ConversionCommon Stock | 1,180,051 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000891839-21-000232 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 8,810,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis. F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 11, 2021 Filed May 12, 2021 16:26 UTC |
MANIAN BALA SDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,586 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0000891839-21-000139 · edgar.xml · derivative · entry 3 MANIAN BALA S · CIK 0000941871 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,586 Underlying: Common Stock · 28,586 shares Expires not disclosed F3 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 16:24 UTC |
Stecyk Chrystyna BedrijDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,586 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0000891839-21-000137 · edgar.xml · derivative · entry 2 Stecyk Chrystyna Bedrij · CIK 0001811625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,586 Underlying: Common Stock · 28,586 shares Expires not disclosed F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 16:22 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 28,586 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0000891839-21-000135 · edgar.xml · derivative · entry 17 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,586 Underlying: Common Stock · 28,586 shares Expires not disclosed F8 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 16:27 UTC |
Goater JeffDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,586 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0000891839-21-000140 · edgar.xml · derivative · entry 6 Goater Jeff · CIK 0001656435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,586 Underlying: Common Stock · 28,586 shares Expires not disclosed F4 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 16:25 UTC |
Yanni BarbaraDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,586 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0000891839-21-000138 · edgar.xml · derivative · entry 4 Yanni Barbara · CIK 0001610561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,586 Underlying: Common Stock · 28,586 shares Expires not disclosed F4 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 16:23 UTC |
Van Strydonck, Gerald E.Director
|
GrantStock Option (Right to Buy) · Derivative | 28,586 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0000891839-21-000136 · edgar.xml · derivative · entry 9 Van Strydonck, Gerald E. · CIK 0001748247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,586 Underlying: Common Stock · 28,586 shares Expires not disclosed F4 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| April 02, 2021 Filed Apr 2, 2021 16:25 UTC |
Smith Ernest S.SVP, Research & CSO
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0000891839-21-000098 · edgar.xml · derivative · entry 6 Smith Ernest S. · CIK 0001747769 · SVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-04-02 F4 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date. Read SEC document |
| April 02, 2021 Filed Apr 2, 2021 16:28 UTC |
Royer Scott E.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0000891839-21-000101 · edgar.xml · derivative · entry 5 Royer Scott E. · CIK 0001747756 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2031-04-02 F4 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date. Read SEC document |
| April 02, 2021 Filed Apr 2, 2021 16:27 UTC |
Zauderer MauriceDirector · President and CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0000891839-21-000100 · edgar.xml · derivative · entry 10 Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-04-02 F6 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date. Read SEC document |
| April 02, 2021 Filed Apr 2, 2021 16:26 UTC |
Leonard John E.SVP, Development
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0000891839-21-000099 · edgar.xml · derivative · entry 7 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2031-04-02 F4 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 16:23 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 4,535 | $0.00 Strike: $2.98 | $0.00 |
DisclosureSEC source: 0000891839-21-000089 · edgar.xml · derivative · entry 16 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,535 Underlying: Common Stock · 4,535 shares Expires 2031-03-31 F8 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2021. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 16:32 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 6,545 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0000891839-21-000004 · edgar.xml · derivative · entry 15 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,545 Underlying: Common Stock · 6,545 shares Expires 2030-12-29 F8 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2020. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 16:31 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0000891839-20-000296 · edgar.xml · derivative · entry 14 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2030-09-28 F8 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2020. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| September 03, 2020 Filed Sep 3, 2020 16:23 UTC |
Royer Scott E.Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0000891839-20-000256 · edgar.xml · derivative · entry 3 Royer Scott E. · CIK 0001747756 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 500 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
| September 03, 2020 Filed Sep 3, 2020 16:23 UTC |
Royer Scott E.Chief Financial Officer
|
Exercise / conversionCommon Stock | 500 | $3.90 | $1,950.00 |
DisclosureSEC source: 0000891839-20-000256 · edgar.xml · nonDerivative · entry 1 Royer Scott E. · CIK 0001747756 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 1, 2020 16:28 UTC |
Scala RobertChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0000891839-20-000254 · edgar.xml · derivative · entry 1 Scala Robert · CIK 0001822706 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock, par value $0.001 · 50,000 shares Expires 2030-08-30 F1 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the September 1, 2020 grant date. Read SEC document |
| July 27, 2020 Filed Jul 27, 2020 16:16 UTC |
Leonard John E.SVP, Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0000891839-20-000213 · edgar.xml · derivative · entry 5 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
| July 27, 2020 Filed Jul 27, 2020 16:16 UTC |
Leonard John E.SVP, Development
|
Exercise / conversionCommon Stock | 1,000 | $3.90 | $3,900.00 |
DisclosureSEC source: 0000891839-20-000213 · edgar.xml · nonDerivative · entry 1 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 16:19 UTC Amendment |
Leonard John E.SVP, Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0000891839-20-000214 · edgar.xml · derivative · entry 6 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 16:19 UTC Amendment |
Leonard John E.SVP, Development
|
Exercise / conversionCommon Stock | 1,000 | $3.90 | $3,900.00 |
DisclosureSEC source: 0000891839-20-000214 · edgar.xml · nonDerivative · entry 2 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 16:19 UTC Amendment |
Leonard John E.SVP, Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,258 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0000891839-20-000214 · edgar.xml · derivative · entry 4 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,150 Underlying: Common Stock · 1,258 shares Expires 2025-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in full as of the date of this report. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 16:19 UTC Amendment |
Leonard John E.SVP, Development
|
Exercise / conversionCommon Stock | 1,258 | $7.10 | $8,931.80 |
DisclosureSEC source: 0000891839-20-000214 · edgar.xml · nonDerivative · entry 1 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2020 Filed Sep 3, 2020 16:16 UTC Amendment |
Leonard John E.SVP, Development
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0000891839-20-000255 · edgar.xml · derivative · entry 2 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
| July 14, 2020 Filed Sep 3, 2020 16:16 UTC Amendment |
Leonard John E.SVP, Development
|
Exercise / conversionCommon Stock | 1,000 | $3.90 | $3,900.00 |
DisclosureSEC source: 0000891839-20-000255 · edgar.xml · nonDerivative · entry 1 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2020 Filed Jul 10, 2020 16:18 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 1,126,760 | $3.55 | $3,999,998.00 |
DisclosureSEC source: 0000891839-20-000208 · edgar.xml · nonDerivative · entry 3 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Friedberg Global-Macro Hedge Fund Ltd. Disclosed balance after: 1,710,093 F2 · ownership.nature: Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 16:30 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 3,756 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0000891839-20-000205 · edgar.xml · derivative · entry 13 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,756 Underlying: Common Stock · 3,756 shares Expires 2030-06-28 F8 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2020. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| May 14, 2020 Filed May 18, 2020 16:21 UTC |
MANIAN BALA SDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,679 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000891839-20-000120 · edgar.xml · derivative · entry 2 MANIAN BALA S · CIK 0000941871 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,679 Underlying: Common Stock · 15,679 shares Expires not disclosed F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 14, 2020 Filed May 18, 2020 16:18 UTC |
Stecyk Chrystyna BedrijDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,087 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000891839-20-000117 · edgar.xml · derivative · entry 1 Stecyk Chrystyna Bedrij · CIK 0001811625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,087 Underlying: Common Stock · 25,087 shares Expires not disclosed F1 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 14, 2020 Filed May 18, 2020 16:23 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,679 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000891839-20-000122 · edgar.xml · derivative · entry 12 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,679 Underlying: Common Stock · 15,679 shares Expires not disclosed F7 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 14, 2020 Filed May 18, 2020 16:22 UTC |
Goater JeffDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,679 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000891839-20-000121 · edgar.xml · derivative · entry 5 Goater Jeff · CIK 0001656435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,679 Underlying: Common Stock · 15,679 shares Expires not disclosed F3 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 14, 2020 Filed May 18, 2020 16:20 UTC |
Van Strydonck, Gerald E.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,679 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000891839-20-000119 · edgar.xml · derivative · entry 8 Van Strydonck, Gerald E. · CIK 0001748247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,679 Underlying: Common Stock · 15,679 shares Expires not disclosed F3 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 14, 2020 Filed May 18, 2020 16:19 UTC |
Yanni BarbaraDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,679 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000891839-20-000118 · edgar.xml · derivative · entry 3 Yanni Barbara · CIK 0001610561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,679 Underlying: Common Stock · 15,679 shares Expires not disclosed F3 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 16:18 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 3,336 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0000891839-20-000086 · edgar.xml · derivative · entry 11 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,336 Underlying: Common Stock · 3,336 shares Expires 2030-03-29 F8 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2020. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| March 30, 2020 Filed Mar 30, 2020 17:20 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 5,000 | $4.06 | $20,300.00 |
DisclosureSEC source: 0000891839-20-000084 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,630,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.